1Y Annualised Return
▼-3.74%
3Y Annualised Return
▲25.65%
5Y Annualised Return
▲29.76%
Over the past
Open
590.00
Prev. Close
597.40
Total Traded Value
5.95 Cr
Market Cap (in crs)
1,173.64
Face Value
10
Turnover (in lacs)
595.07
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
168.18 Cr | 146.55 Cr | 161.21 Cr | 147.28 Cr | 142.49 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
645.71 Cr | 614.97 Cr | 532.78 Cr | 482.12 Cr | 429.85 Cr | 397.53 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
11.58 Cr | 20.77 Cr | 26.33 Cr | 23.67 Cr | 18.6 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
82.35 Cr | 93.3 Cr | 72.9 Cr | 69.36 Cr | 62.25 Cr | 51.47 Cr |
Lincoln Pharmaceuticals Ltd reported a 3.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 28.5%.
Its expenses for the quarter were up by 0.4% QoQ and 28.1% YoY.
The net profit decreased 10.4% QoQ and increased 48.1% YoY.
The earnings per share (EPS) of Lincoln Pharmaceuticals Ltd stood at 9.3 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 56090 Rs | 107031 Rs |
Week Rs | 59016 Rs | 109847 Rs |
Month Rs | 50646 Rs | 97172 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 1,573.18 | 101.01 | 185.5 | 148.43 | 9.39% | 25.94% | -15.29% | 41.69% | 88.75% | 0.33% | 22.80 | 42.57 | 1.49 | |
- | 1,548.50 | 130.48 | 328.04 | 235.02 | 0.62% | 6.27% | -13.40% | 70.41% | 97.52% | 1.07% | 38.97 | 42.57 | 6.46 | |
- | 1,268.50 | 115 | 317 | 144.51 | 2.07% | 4.44% | -52.07% | -36.98% | 76.69% | 0.00% | 53.73 | 42.57 | 4.48 | |
- | 1,082.02 | 148.5 | 245.7 | 215.45 | 2.10% | 24.31% | 0.00% | 0.00% | 0.00% | 0.69% | 22.91 | 42.57 | 3.33 | |
- | 1,067.45 | 481 | 1070 | 1,010.00 | 10.98% | 33.62% | 22.67% | 94.21% | 162.77% | 0.00% | 26.76 | 42.57 | 4.03 | |
Remus Pharmaceuticals Ltd. | - | 1,914.10 | - | - | - | - | - | - | - | - | - | - | - | - |
As of 13 Jun, 2025, LINCOLN share price is ₹586. The stock opened at ₹590 and had closed at ₹597.4 the previous day. During today’s trading session, LINCOLN share price moved between ₹567.05 and ₹599.90, with an average price for the day of ₹583.00. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹979.50. In terms of performance, LINCOLN share price has declined by 37% over the past six months and has declined by 3.74% over the last year.
Lincoln Pharmaceuticals share price is ₹584.4 in NSE and ₹584.1 in BSE as on 13/6/2025.
Lincoln Pharmaceuticals share price in the past 1-year return was -5.58. The Lincoln Pharmaceuticals share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 979.5.
The market cap of Lincoln Pharmaceuticals is Rs. 1173.64 Cr. as of 13/6/2025.
The PE ratios of Lincoln Pharmaceuticals is 14.24 as of 13/6/2025.
The PB ratios of Lincoln Pharmaceuticals is 1.74 as of 13/6/2025
You can easily buy Lincoln Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Lincoln Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.